Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.